Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008

Rebecca E. Rosenberg, David S. Mandell, Janet E. Farmer, J. Kiely Law, Alison R. Marvin, Paul A. Law

Research output: Contribution to journalArticlepeer-review

Abstract

Patterns of current psychotropic medication use among 5,181 children with autism spectrum disorders (ASD) enrolled in a Web-based registry were examined. Overall, 35% used at least one psychotropic medication, most commonly stimulants, neuroleptics, and/or antidepressants. Those who were uninsured or exclusively privately insured were less likely to use ≥3 medications than were those insured by Medicaid. Psychiatrists and neurologists prescribed the majority of psychotropic medications. In multivariate analysis, older age, presence of intellectual disability or psychiatric comorbidity, and residing in a poorer county or in the South or Midwest regions of the United States increased the odds of psychotropic medication use. Factors external to clinical presentation likely affect odds of psychotropic medication use among children with ASD.

Original languageEnglish (US)
Pages (from-to)342-351
Number of pages10
JournalJournal of Autism and Developmental Disorders
Volume40
Issue number3
DOIs
StatePublished - Mar 1 2010

Keywords

  • Asperger syndrome
  • Autism
  • Health disparity
  • Medication
  • Pervasive developmental disorder

ASJC Scopus subject areas

  • Developmental and Educational Psychology

Fingerprint Dive into the research topics of 'Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008'. Together they form a unique fingerprint.

Cite this